Effect of the external use of flexible nanonipsomes methotrexate on the levels of serum interferon-gamma and interleukin-4 in rats with rheumatoid arthritis
Juan Wang,Qing-hua Liang,Rong Fan,T Tang,XG Xiong,J Chen
DOI: https://doi.org/10.3321/j.issn:1673-8225.2007.01.024
2007-01-01
Abstract:Aim: To study the changes in serum interferon-gamma (IFN-γ) and interleukin 4 (IL-4) in rats with rheumatoid arthritis (RA) after externally administrated with methotrexate (MTX) made by flexible nanonipsomes. Methods: The experiment was conducted in the Institute of Combined Traditional Chinese Medicine and Western Medicine, Xiangya Hospital of Central South University between March and November 2005. Totally 80 healthy SD rats were randomly divided into 5 groups: Normal control group (n=10), while other 70 rats were made into RA models by subcutaneous injection of type II collagen and complete Freund Adjuvant, and then randomly divided into model group (n=10), 0.5% MTX group (n=20), 0.25% flexible nanonipsomes MTX group (n=20) and 0.5% flexible nanonipsomes MTX group (n=20). Rats in the normal control group drank water freely; rats in the model group were perfused with 1.5 mL of distilled water once a day. Rats in other groups were administered at 7 days after primary immunization, and then were externally painted with 0.5% MTX, 0.25% flexible nanonipsomes MTX and 0.5% flexible nanonipsomes MTX on the right postpedes respectively with 2.0 g to 4.0 g for each rat (according to the size of the articles) once a week. Articular symptoms were evaluated with the integral of arthritis index, and the higher the index was, the severer the arthritis was. Enzyme linked immunosorbent assay (ELISA) was adopted to detect the level of IFN-γ and IL-4 in the serum of rats on the 45th day after administration. Results: Totally 80 enrolled rats all entered the final analysis. 1 There was no significant difference in the integral of arthritis index at 14 days before administration among all groups, while with the time prolonging, the integral of arthritis index in the model group increased and peaked in the 0.5% MTX group, 0.25% flexible nanonipsomes MTX group and 0.5% flexible nanonipsomes MTX group, but they were still lower than that in the model group (which were 1.51±0.99, 0.98±0.57, 0.88±0.49, 1.68±1.24, t =2.956, 5.461, 5.244, P < 0.01 respectively). 2 Forty-five days after administration, the level of IFN-γ in the model group, 0.5% MTX group, 0.25% flexible nanonipsomes MTX group and 0.5% flexible nanonipsomes MTX group were obviously higher than that in the normal control group, whereas the level of IL-4 was obviously lower than that in the normal control group [IFN-γ: (120.75±1.43), (104.41±1.71), (88.75±1.58), (83.60±1.86), (56.15±2.07)ng/L, t =-64.016, -67.970, -36.928, -48.092, P < 0.01; IL-4: (23.28±0.13), (36.45±0.15), (46.46±0.16), (48.47±0.12), (61.23±0.27)ng/L, t = 398.098, 328.973, 179.924, 186.796, P < 0.01]. The level of IFN-γ in 0.5% MTX group, 0.25% flexible nanonipsomes MTX group and 0.5% flexible nanonipsomes MTX group were obviously lower than that in the model group (t =21.387, 46.365, 43.639, P < 0.01), and the level of IL-4 was significantly higher than that in the model group (t =-238.74, -514.575, -385.096, P < 0.01). The level of IFN-γ in 0.25% flexible nanonipsomes MTX group and the 0.5% flexible nanonipsomes MTX group were obviously lower than that in 0.5% MTX group (t =36.581, 30.124, P < 0.01), while the level of IL-4 were remarkably higher (t =-282.406, -203.685, P < 0.01). The levels of IFN-γ and IL-4 in 0.25% flexible nanonipsomes MTX group were not significantly different from those in 0.5% flexible nanonipsomes MTX group (P > 0.05). Conclusion: External using of flexible nanonipsomes MTX can down-regulate IFN-γ and up-regulate the level of IL-4 through its intelligent controlled releasing, and the effect is obviously better than normal external application of MTX.